Anne Sophie Michallet

Summary

Affiliation: Hospices Civils de Lyon
Country: France

Publications

  1. doi request reprint First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis
    Anne Sophie Michallet
    Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, 165 Chemin du Grand Revoyet, 69495 Pierre Benite, France Electronic address
    J Geriatr Oncol 4:141-7. 2013
  2. doi request reprint Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia
    Anne Sophie Michallet
    Hospices Civils de Lyon, Department of Hematology, Lyon Sud University Hospital, Pierre Benite, France
    Leuk Lymphoma 52:1401-3. 2011
  3. ncbi request reprint Maintenance therapy in follicular lymphoma
    Anne Sophie Michallet
    Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Benite, Lyon, France
    Curr Opin Oncol 23:449-54. 2011
  4. ncbi request reprint Role of early PET in the management of diffuse large B-cell lymphoma
    Anne Sophie Michallet
    Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165 Chemin du Grand Revoyet, Pierre Benite, Lyon, France
    Curr Opin Oncol 22:414-8. 2010
  5. doi request reprint Recent developments in the treatment of aggressive non-Hodgkin lymphoma
    Anne Sophie Michallet
    Hematologie, CH Lyon Sud, 69495 Pierre Benite, France
    Blood Rev 23:11-23. 2009
  6. doi request reprint Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma
    Ewa Lech-Maranda
    Equipe d Accueil Pathologie des Cellules Lymphoïdes, Universite Claude Bernard, Lyon, France
    Arch Immunol Ther Exp (Warsz) 61:165-74. 2013
  7. pmc Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia
    Emmanuelle Bouvet
    Department of Hematology, Purpan University Hospital, Toulouse, France
    Haematologica 98:65-70. 2013
  8. ncbi request reprint Autologous hematopoietic stem cell transplantation for adults with acute myeloid leukemia in complete remission: the Edouard Herriot Hospital experience
    Anne Sophie Michallet
    Service d Hematologie, Hopital Edouard Herriot, Lyon, France
    Hematology 11:157-64. 2006
  9. ncbi request reprint Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis
    Herve Ghesquieres
    Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d Hematologie, France
    J Clin Oncol 24:5234-41. 2006
  10. ncbi request reprint Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma
    Ewa Lech-Maranda
    Equipe d Accueil Pathologie des Cellules Lymphoïdes, Universite Claude Bernard, Lyon, France
    Eur Cytokine Netw 17:60-6. 2006

Collaborators

Detail Information

Publications18

  1. doi request reprint First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis
    Anne Sophie Michallet
    Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, 165 Chemin du Grand Revoyet, 69495 Pierre Benite, France Electronic address
    J Geriatr Oncol 4:141-7. 2013
    ..As a result, no definitive treatment exists for elderly patients, especially less medically fit patients...
  2. doi request reprint Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia
    Anne Sophie Michallet
    Hospices Civils de Lyon, Department of Hematology, Lyon Sud University Hospital, Pierre Benite, France
    Leuk Lymphoma 52:1401-3. 2011
    ..5%) and AIHA...
  3. ncbi request reprint Maintenance therapy in follicular lymphoma
    Anne Sophie Michallet
    Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Benite, Lyon, France
    Curr Opin Oncol 23:449-54. 2011
    ..This article reviews the potential benefit of maintenance therapy for patients with follicular lymphoma...
  4. ncbi request reprint Role of early PET in the management of diffuse large B-cell lymphoma
    Anne Sophie Michallet
    Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165 Chemin du Grand Revoyet, Pierre Benite, Lyon, France
    Curr Opin Oncol 22:414-8. 2010
    ..This article reviews the role of interim fluorine-18-fluorodeoxyglucose (FDG)-PET in the management of aggressive non-Hodgkin lymphoma...
  5. doi request reprint Recent developments in the treatment of aggressive non-Hodgkin lymphoma
    Anne Sophie Michallet
    Hematologie, CH Lyon Sud, 69495 Pierre Benite, France
    Blood Rev 23:11-23. 2009
    ..Effective delivery of dose-dense regimens requires granulocyte colony-stimulating factor support, which should also be considered for standard CHOP. A key question for the future is whether R-CHOP-14 is superior to R-CHOP-21...
  6. doi request reprint Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma
    Ewa Lech-Maranda
    Equipe d Accueil Pathologie des Cellules Lymphoïdes, Universite Claude Bernard, Lyon, France
    Arch Immunol Ther Exp (Warsz) 61:165-74. 2013
    ..VEGF may be a useful marker for selecting the patients for whom new treatment approaches, especially those based on VEGF inhibitors, could be recommended...
  7. pmc Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia
    Emmanuelle Bouvet
    Department of Hematology, Purpan University Hospital, Toulouse, France
    Haematologica 98:65-70. 2013
    ..This study shows that reduction of fludarabine-cyclophosphamide and, more importantly, of rituximab doses seriously interferes with progression-free survival...
  8. ncbi request reprint Autologous hematopoietic stem cell transplantation for adults with acute myeloid leukemia in complete remission: the Edouard Herriot Hospital experience
    Anne Sophie Michallet
    Service d Hematologie, Hopital Edouard Herriot, Lyon, France
    Hematology 11:157-64. 2006
    ..Results in adults who experience a relapse after conventional chemotherapy support the use of autologous HSCT as salvage therapy if such patients achieve a subsequent CR...
  9. ncbi request reprint Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis
    Herve Ghesquieres
    Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d Hematologie, France
    J Clin Oncol 24:5234-41. 2006
    ..The characteristics and prognosis of these particular DLBCL are not well known...
  10. ncbi request reprint Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma
    Ewa Lech-Maranda
    Equipe d Accueil Pathologie des Cellules Lymphoïdes, Universite Claude Bernard, Lyon, France
    Eur Cytokine Netw 17:60-6. 2006
    ..The plasma concentration of IL-10 may be a useful marker for evaluation of disease activity...
  11. doi request reprint Retreatment with rituximab in 178 patients with relapsed and refractory B-cell lymphomas: a single institution case control study
    Anna Johnston
    Department of Hematology, Hospices Civils de Lyon, Lyon, France
    Leuk Lymphoma 51:399-405. 2010
    ..Relapse occurring after rituximab-containing therapy appears to be more aggressive than that occurring after chemotherapy alone. The outcome of retreatment, in terms of progression-free survival, is similar to that of primary treatment...
  12. doi request reprint Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index
    Ewa Lech-Maranda
    Equipe Pathologie des Cellules Lymphoïdes, UMR CNRS 5239, Universite Claude Bernard, Lyon, France
    Arch Immunol Ther Exp (Warsz) 58:131-41. 2010
    ..This model may help to identify patients in a given IPI risk group for whom more accurate and risk-adapted treatment could be advised...
  13. doi request reprint Maintenance therapy in diffuse large B-cell lymphoma
    Anne Sophie Michallet
    Department of Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Curr Opin Oncol 24:461-5. 2012
    ..In this article, we focused on the role of maintenance therapy in diffuse large B-cell lymphoma (DLBCL)...
  14. doi request reprint Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC
    Cyrille Touzeau
    Department of Hematology, University Hospital, Nantes, France
    Ann Hematol 93:233-42. 2014
    ....
  15. pmc Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma
    Adrien Chauchet
    Department of Hematology, Centre Hospitalier Universitaire Lyon Sud, Pierre Benite, France
    J Hematol Oncol 5:27. 2012
    ..Considering the rarity of this lymphoma in Europe, we conducted a multicentric retrospective study on nasal-type NK/T cell lymphoma to determine the optimal induction strategy and identify prognostic factors...
  16. ncbi request reprint Bruton's tyrosine kinase inhibitors: lessons learned from bench-to-bedside (first) studies
    Loic Ysebaert
    aDepartment of Hematology, IUC Toulouse Oncopole, and Cancer Research Center of Toulouse CRCT, INSERM UMR1037 CNRS ERL5294, Toulouse bService d Hématologie, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Curr Opin Oncol 26:463-8. 2014
    ..The sheer amount of clinical data published since last year now requires reinterpretation in light of recently published findings on BTK...
  17. ncbi request reprint Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma
    Catherine Thieblemont
    Service d Hematologie Clinique, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Cancer 104:1434-41. 2005
    ..The authors evaluated the efficacy of chemotherapy combined with rituximab followed by high-dose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL)...
  18. ncbi request reprint Long-term persistent lymphopenia in hematopoietic stem cell donors after donation for donor lymphocyte infusion
    Franck E Nicolini
    Service d Hematologie, Hopital Edouard Herriot, Lyon, France
    Exp Hematol 32:1033-9. 2004
    ..To analyze the consequences of lymphocyte donations on lymphopoiesis in donors having previously undergone hematopoietic stem cell collection for allogeneic stem cell transplantation...